Rosa-Neto P - Search Results

1

Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum.

Bieger A, Rocha A, Bellaver B, Machado L, Da Ros L, Borelli WV, Therriault J, Macedo AC, Pascoal TA, Gauthier S, Rosa-Neto P, Zimmer ER. Bieger A, et al. J Prev Alzheimers Dis. 2023;10(3):401-417. doi: 10.14283/jpad.2023.54. J Prev Alzheimers Dis. 2023. PMID: 37357281

2

Use of biomarkers in clinical trials of Alzheimer disease: from concept to application.

Wu L, Rosa-Neto P, Gauthier S. Wu L, et al. Mol Diagn Ther. 2011 Dec 1;15(6):313-25. doi: 10.1007/BF03256467. Mol Diagn Ther. 2011. PMID: 22188635

3

Early-onset familial Alzheimer's disease (EOFAD).

Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S. Wu L, et al. Can J Neurol Sci. 2012 Jul;39(4):436-45. doi: 10.1017/s0317167100013949. Can J Neurol Sci. 2012. PMID: 22728850 Review.

4

Prevention strategies for Alzheimer's disease.

Gauthier S, Wu L, Rosa-Neto P, Jia J. Gauthier S, et al. Transl Neurodegener. 2012 Jun 28;1(1):13. doi: 10.1186/2047-9158-1-13. Transl Neurodegener. 2012. PMID: 23210473 Free PMC article.

5

Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.

Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Gauthier S, et al. Prog Neurobiol. 2013 Nov;110:102-13. doi: 10.1016/j.pneurobio.2013.01.003. Epub 2013 Apr 8. Prog Neurobiol. 2013. PMID: 23578568 Review.

6

How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?

Gauthier S, Leuzy A, Rosa-Neto P. Gauthier S, et al. Neurodegener Dis. 2014;13(2-3):197-9. doi: 10.1159/000353748. Epub 2013 Aug 7. Neurodegener Dis. 2014. PMID: 23942173 Review.

7

Dementia: Disclosure of results to participants in dementia research.

Gauthier S, Rosa-Neto P. Gauthier S, et al. Nat Rev Neurol. 2013 Nov;9(11):608-9. doi: 10.1038/nrneurol.2013.213. Epub 2013 Oct 22. Nat Rev Neurol. 2013. PMID: 24145370 No abstract available.

8

Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.

Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S. Leuzy A, et al. Int Psychogeriatr. 2014 May;26(5):703-7. doi: 10.1017/S1041610214000118. Epub 2014 Feb 13. Int Psychogeriatr. 2014. PMID: 24524685 No abstract available.

9

In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals.

Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P. Zimmer ER, et al. Transl Neurodegener. 2014 Mar 15;3(1):6. doi: 10.1186/2047-9158-3-6. Transl Neurodegener. 2014. PMID: 24628994 Free PMC article.

10

Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.

Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S. Leuzy A, et al. Amyloid. 2014 Sep;21(3):143-8. doi: 10.3109/13506129.2014.926267. Epub 2014 Jun 11. Amyloid. 2014. PMID: 24919109 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters